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Background: Accumulating evidence suggests risk of cognitive im-
pairment is declining in high-income countries. Much of this research 
uses longitudinal surveys in which learning over repeated tests may 
bias results. We analyze trends in cognitive impairment in the United 
States, accounting for prior test experience and selective mortality.
Methods: We use the Health and Retirement Study, a population-
based, nationally representative panel dataset and include individuals 
ages 50 years and older in 1996–2014 (n = 32,784). We measure 
cognitive impairment and dementia using standard cutpoints of the 
modified Telephone Interview for Cognitive Status. We estimate lo-
gistic regression models for any impairment and dementia over time, 
adjusting for age, sex, and race/ethnicity, comparing models with and 
without adjustment for practice effects and education. We examine 
heterogeneity in trends by age, sex, race/ethnicity, and education.
Results: Models not controlling for test experience suggest that risk 
of cognitive impairment and dementia decreased over the study pe-
riod. Controlling for test experience reverses the trend. In our primary 
models, prevalence of any cognitive impairment increased for women 
from 18.7% to 21.2% (annual change 0.7%, 95% confidence interval 
[CI], 0.1%, 1.3%) and for men from 17.6% to 21.0% (annual change 
1.0%, CI, 0.5%, 1.4%). For dementia, women’s annual increase was 
1.7% (CI, 0.8%, 2.6%) and men’s 2.0% (CI, 1.0%, 2.9%). If not for 
education, the increase would have been stronger. Increased risk was 
particularly rapid for Latinas, the least educated, and older ages.
Conclusions: Risk of cognitive impairment increased from 1996 
to 2014. Uncovering determinants of increasing cognitive impair-
ment risk should become a research priority. See video abstract: 
http://links.lww.com/EDE/B702.
Keywords: Cognitive impairment; Dementia; Learning; Practice 
effects; Trends
(Epidemiology 2020;31: 745–754)
Increasing life expectancy and population aging have inspired a surge of research on aging-related cognitive impairment, 
including dementia. Approximately 5.8 million people in the 
United States have a diagnosis of Alzheimer’s disease (AD), 
comprising 60%–80% of dementia cases.1 Deaths attributable 
to AD rose by two-thirds from 2000 to 2013, pushing it into 
the sixth leading cause of death in the United States.2 Trends 
in cognitive impairment and dementia are, therefore, critically 
important for population health and health policy.
Recent research, however, suggests that risk of later-life 
cognitive impairment may be declining in many high-income 
countries, including the United States.3–12 Three of the oft-
proposed mechanisms for such trends are, first, more recent 
cohorts have higher educational attainment, building protec-
tive cognitive/brain reserve.13–16 Second, recent cohorts had 
more health-promoting early-life environments, such as better 
nutrition.7,17–19 Third, medical developments for treatment of 
vascular diseases, e.g., the use of statins, have decreased the 
incidence of risk factors for cognitive impairment.3,8,20,21
An important part of the evidence on declining risk of 
cognitive impairment comes from nationally representative 
longitudinal studies. We argue that these studies are likely to 
be biased because the longitudinal nature is not appropriately 
accounted for in the study design.22 In particular, the Health 
and Retirement Study (HRS), a large national, longitudinal 
survey, has been used repeatedly to examine dementia trends. 
Results from the HRS and other longitudinal studies con-
sistently suggest that trends in cognitive impairment in the 
United States are improving.5,23–25 However, most of these 
studies (with the exception of Choi et al.26) do not account for 
one potentially important factor—individuals in the HRS are 
surveyed repeatedly using the same (counting backwards, se-
rial 7s) or similar (word recall) metrics. An extensive body of 
literature, especially in medical fields, suggests that repeated 
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exposure to analogous tests creates a “practice effect” that 
may mask cognitive decline and bias trends.22,27–32
Practice effects are a specific type of panel conditioning, 
whereby respondents’ responses are impacted by previous par-
ticipation.33–38 In the HRS, the average number of tests taken 
among the individuals in the 1996–1998 waves is 1.4; in the 
2000–2002 waves, it is 3.0; and in the 2012–2014 waves, it is 
6.0. As, over time, individuals who repeatedly respond to the 
survey accumulate test-taking experience, test scores may in-
crease even though cognitive ability did not.28,29,32,39 Thus, an 
increase in test scores over time may reflect either true increase 
or greater test-taking experience. The effect size associated with 
panel conditioning varies across contexts, and evidence suggests 
that the magnitude of practice effect for cognitive function test-
ing may be large enough to mask several years of aging.40 There-
fore, when analyzing time trends in cognition, adjusting for the 
changing distribution of number of tests (“practice effects”) is 
important. Adjusting for practice effects can be done in a mul-
tivariate regression model in the same way that one adjusts for 
other variables, such as racial/ethnic or educational composition.
We estimate age-specific time trends in cognitive im-
pairment in the United States ages 50 and older population 
using a large-scale, population-based, nationally representa-
tive, longitudinal survey. Our key contributions are that we 
estimate the population-level trends after controlling for prior 
test experience, providing less-biased estimates than prior lit-
erature; we model multiple specifications of practice effects, 
testing the sensitivity of estimated trends to measurement; we 
also analyze to what extent the estimated trends would be bi-
ased if test experience is ignored. Most prior studies do not 
account for test experience, and to our knowledge, no popula-
tion-based study using the HRS has analyzed the magnitude 
of the bias when prior test experience is ignored. We addition-
ally examine heterogeneity in time trends by age, sex, race/
ethnicity, and educational attainment. Our results show that 
without adjustment average cognitive function scores seem to 
be increasing over time; but, once practice effects are adjusted, 
the time trends are flat or negative.
METHODS
Study Population
The Health and Retirement Study (HRS) is a nationally 
representative, biennial panel survey of US residents age 50 
and older and their spouses. The University of Michigan Insti-
tutional Review Board granted ethical approval for the Health 
and Retirement Study. It includes information on health, dem-
ographic factors, educational attainment, and a version of the 
Telephone Interview for Cognitive Status (TICS-M), specifi-
cally modified to be sensitive to pathological cognitive decline 
and minimize ceiling effects.39,41 The University of Michigan 
conducts the HRS,42,43 which is sponsored by the National In-
stitute on Aging (grant number NIA U01AG009740). We use 
RAND Version P of the HRS, selecting respondents ages 50 
and older and all the waves in which the TICS-M measures we 
utilize were administered consistently (1996–2014). We use 
the University of Michigan Survey Research Center’s imputed 
TICS-M values.44
The raw HRS data set contains 37,495 individuals with 
226,564 respondent or proxy interviews. The observation count 
reduces because of restrictions to age 50 and over and waves 
1996–2014 (38,493 observations), exclusion of zero-weighted 
observations (7,503 observations), missing values in the regres-
sion variables (1,199 observations), and data anomalies, such as 
death being recorded before valid interview records (133 obser-
vations). The resulting 179,236 observations correspond to 
32,784 subjects in the sample for our logistic regression mod-
els. In the eAppendix (http://links.lww.com/EDE/B677), we 
report results that use a continuous cognitive score as the out-
come; in these results proxy responses that are categorical were 
excluded. As a result the sample size was 165,926 observations, 
corresponding to 31,696 subjects (13,310 fewer observations).
Procedures
Cognitive impairment is defined based on total score 
on TICS-M measures that reflect neurophysiological health:45 
immediate (0–10 points) and delayed recall (0–10 points), 
serial 7s (0–5 points), and backward counting from 20 (0–2 
points). The range is 0–27; higher scores indicate better cogni-
tive function. Although score on the TICS-M is not indicative 
of a clinical mild cognitive impairment or dementia diagnosis, 
we use standard cutpoints—no cognitive impairment (NCI) 
12–27, cognitive impairment no dementia (CIND) 7–11, and 
dementia 0–6—that were validated against the Aging, Dem-
ographics, and Memory Study (ADAMS).46 The ADAMS 
selects a subset of respondents from the HRS sample to un-
dergo extensive clinical evaluation for cognitive impairment, 
which has subsequently been used by Langa, Crimmins, and 
others to establish cutpoints in the HRS for CIND and de-
mentia.46,47 For simplicity, we adhere to the norm of refer-
ring to the categories as CIND and dementia, despite that the 
lack of clinical diagnosis means it is only probable CIND or 
dementia. We combine CIND and dementia to create a cate-
gory “any impairment” and analyze both any impairment and 
dementia.
We follow Langa and colleagues5 in using a measure 
constructed from proxy interviews to indicate categories of 
cognitive impairment when respondents do not complete the 
TICS-M. Before 2000, this includes the proxy’s assessment 
of the respondent’s memory (0–4) and number of difficulties 
with instrumental activities of daily living (0–5) (NCI = 0–2, 
CIND = 3–4, and dementia = 5–9 points). From 2000 to 2014, 
the evaluation of the interviewer is included (0 = no cognitive 
limitation, 1 = some cognitive limitation, 2 = cognitive limi-
tation prevents completion of the interview). For these years, 
0–2 is NCI, 3–5 is CIND, and 6–11 is dementia. Our results 
using categorical coding of time or waves 2000–2002 as the 
reference time (Figure 1) show that our conclusions are robust 
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to this shift in definition. We also include a control for inter-
view mode (face-to-face, telephone, or proxy).
In our primary regressions, we include time as a con-
tinuous variable (exact date of interview). We also analyze 
time trends using categorical values of time, corresponding 
to paired HRS waves (1995–1998, 2000–2002, 2004–2006, 
2008–2010, 2012–2014). We include practice effects as a cat-
egorical variable for test number (first, second, third to fourth, 
fifth–seventh, and eighth test or higher), and, in alternative 
specifications, analyze test number as a continuous variable, 
square root of continuous test number, and broader categories 
(first, second, third, fourth, or higher). Proxy interviews re-
ceive their own category and do not increment the test number 
count, as they do not accumulate practice effects.
We control for sex (self-reported as binary, woman/
man), race/ethnicity (nonHispanic White, Black [Hispanic or 
nonHispanic], nonBlack Hispanic, and nonHispanic “Other”; 
henceforth, White, Black, Latinx, Other), education (less than 
high school/general educational development, high-school di-
ploma, associate degree or higher), and age at interview (age 
and age squared or age group 50–64, 65–74, 85+). We use 
RAND’s complex survey weights that include residents of 
nursing homes and that were designed for longitudinal anal-
ysis (variable RwWTCRNH).48
Statistical Analyses
Using a sequence of logistic regression models, we 
regress a binary indicator of any impairment or dementia 
on time and selected covariates. Model 1 includes age, age 
squared, race/ethnicity, and an interaction between sex and in-
terview mode (women with proxies are more than twice as 
likely to be reported as cognitively impaired than men with 
proxies). This model is expected to replicate the results on 
positive trends in cognitive function that others have found. 
Model 2 introduces controls for test number. This model is 
our primary model and is expected to produce less-biased esti-
mates of time trends than model 1, as it removes the biasing 
effect of practice. Model 3 includes education as a potential 
mechanism driving trends in cognitive impairment. To ana-
lyze heterogeneity in trends across subpopulations, we esti-
mate model 2, adding interactions between time and: sex, age, 
race/ethnicity, and education.
Furthermore, we conduct a series of robustness checks 
that respond to methodologic concerns, including analyzing 
the robustness of our results to time-on-study and multicol-
linearity among age, period, and practice effects. We restrict 
analyses to individuals who have the same test number and 
vary how we specify time, age, and practice effects. Addi-
tional robustness checks, presented in the eAppendix; http://
links.lww.com/EDE/B677, include the following: (1) we rep-
licate models 1–3 using a continuous measure of cognitive 
function; (2) we restrict the sample to respondents ages 65 
and over to allow comparisons with other findings; (3) we test 
various cutpoints for categorizations of any impairment and 
dementia to examine sensitivity to cutpoint definition; (4) we 
estimate a joint model that includes both mortality and meas-
urement of cognitive function to investigate whether selective 
mortality influences our results; and (5) to determine whether 
FIGURE 1. Odds ratios and 95% 
confidence intervals for time from 
logistic regression models of any 
cognitive impairment or dementia 
(Model 1 includes pairs of survey 
waves, age, age squared, race/eth-
nicity, and the interaction between 
gender and interview mode. 
Model 2 adds test number. Model 
3 adds educational attainment).
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multicollinearity biases results, we conduct a simulation in 
which we study whether the parameters can be reliably esti-
mated from a dataset whose correlation structure mimics that 
of the actual data.
RESULTS
Descriptive results shown in Table 1 document declines 
in percent of any cognitive impairment and dementia, al-
though mean cognitive function score remains stable. Mean 
test number increases across time. There is a strong decline 
across time in percent proxy interviews. The sample becomes 
more ethnically diverse and more highly educated across time.
Table 2 shows the regression results for any cognitive 
impairment and dementia. Model 1 shows that if one does not 
account for prior tests, the time trends in cognitive impair-
ment appear positive, with a substantial decline in both any 
cognitive impairment and dementia. Over a 10-year period, 
odds of any impairment decrease by a factor of 0.85 (95% 
CI = 0.82, 0.89). For dementia, the odds decrease by 0.87 
(95% CI = 0.82, 0.93). Model 2 includes test number as a 
covariate. This changes the estimated time trend such that 
odds of any impairment increase by a factor of 1.14 (95% 
CI = 1.06, 1.22) over a 10-year period. For dementia, the cor-
responding increase is 1.29 (95% CI = 1.16, 1.44). Model 3 
introduces educational attainment as a covariate and shows 
that the increases would have been larger if educational attain-
ment had not increased, with odds of any impairment increas-
ing by a factor of 1.37 (95% CI = 1,29, 1.46) and dementia 
by 1.54 (95% CI = 1.39, 1.70). Figure 1 illustrates the results 
using survey waves instead of continuous time and confirms 
that once practice effects are controlled (model 2), the odds of 
cognitive impairment are lower in 1996–1998 compared with 
2000–2002 and higher in all later waves, suggesting increased 
trends in prevalence of cognitive impairment over time. Al-
though the association is not strictly linear, across the period 
1996–2014, there is no evidence of improvement.
Table 3 shows predicted prevalence of cognitive impair-
ment based on models 1 and 2. Not controlling for practice 
effects (model 1), the results consistently suggest declining 
trends for any cognitive impairment and dementia for women 
and men. Controlling for test experience (model 2) reverses 
the trend: prevalence of any cognitive impairment increased 
for women from 18.7% to 21.2% (annual change 0.7%, 
CI = 0.1%, 1.3%) and for men from 17.6% to 21.0% (annual 
change 1.0%, CI = 0.5%, 1.4%). For dementia, the change 
among women was from 5.1% to 7.0% (annual change 1.7%, 
CI = 0.8%, 2.6%) and among men from 3.8% to 5.4% (annual 
change 2.0%, CI = 1.0%, 2.9%).
Table 4 shows the odds ratios of dementia for a 10-year 
change in time for models 1 and 2 for subpopulations. Most 
groups experience increasing dementia once we control for 
practice effects. We find no evidence for a gender difference 
(women OR = 1.31, CI = 1.13, 1.52; men = 1.28, CI = 1.13, 1.44). 
Analyses by age show that the pattern is strongest among the 
oldest (age 85+) compared with younger groups. Odds of de-
mentia have increased across time among Latinas (OR = 1.79, 
TABLE 1. Descriptive Characteristics of the Health and Retirement Study Analytical Sample Over Time (1996–2014), Number 
of Persons 32,784
1996–1998 2000–2002 2004–2006 2008–2010 2012–2014 Total
Age (years, mean) 66.4 67.8 65.9 66.4 67.0 66.7
Women % 55.2 55.8 54.6 54.5 54.2 54.8
Any cognitive impairment % 20.0 22.1 19.5 19.5 18.6 19.8
Dementia % 5.0 6.8 5.6 5.2 4.7 5.4
Cognitive function score (mean; range 0–27) 15.7 15.6 15.7 15.6 15.7 15.6
Number of tests (mean) 1.4 3.0 4.0 5.0 6.0 4.2
Proxy interviews % 6.0 10.2 7.1 5.5 4.4 6.5
Race/ethnicity %       
  White 83.3 82.4 80.6 79.2 77.8 80.3
  Black 9.0 9.3 9.5 9.9 10.2 9.7
  Latinx 5.7 6.1 7.2 7.9 8.4 7.2
  Other 2.0 2.2 2.7 3.1 3.5 2.8
Educational attainment %       
  Less than high school 26.2 23.7 18.7 15.9 13.6 18.8
  HS/GED/some collegea 52.2 52.6 52.7 52.1 51.5 52.2
  Associate degree or higher 21.6 23.7 28.6 32.0 34.9 29.0
Person-Waves 33,646 35,722 36,654 36,971 36,243 179,236
All measures, including any cognitive impairment and dementia, include information from proxy informants, except continuous cognitive function score, which is available for 
self-respondents only, and number of tests that are calculated based on self-responses only.
aHS indicates high school. GED is general educational development, a set of tests that provides certification considered equivalent to a US high school diploma.
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CI = 1.39, 2.29), White men (OR = 1.31, CI = 1.13, 1.51), 
White women (OR = 1.29, CI = 1.13, 1.48), and Black men 
(OR = 1.24, CI = 1.06, 1.45). Within educational groups, the 
odds ratios for the time trend do not indicate improvement 
even before controlling for practice effects. When controlling 
for practice effects, each education group shows higher odds 
ratios for time, and this is strongest among the least educated.
Robustness
The eAppendix; http://links.lww.com/EDE/B677 pres-
ents results and detailed discussion of our extensive robustness 
analyses. In summary, analyses in which we use a continuous 
score (eTable 1; http://links.lww.com/EDE/B677) restrict the 
sample to ages 65 and older (eTables 2, 3; http://links.lww.
com/EDE/B677), and test for sensitivity in the cutpoints for 
cognitive impairment (eTable 4; http://links.lww.com/EDE/
B677) all suggest that our findings of increasing odds in cog-
nitive impairment are robust. Joint models in which we si-
multaneously model cognitive impairment and death do not 
indicate that our results are biased by selective mortality 
(eTable 5; http://links.lww.com/EDE/B677). We also use three 
approaches to test whether collinearity among age, time, and 
practice effects biases results.
First, we use a subsampling strategy to purge estimation 
results from the effects of prior test experience and time-in-study. 
We create four subsamples restricted to first, second, fourth, or 
sixth test, and estimate for each subsample the association be-
tween cognitive impairment and time. Since within subsample 
the number of tests taken is constant, we do not need to con-
trol for number of tests. Only age, age squared, race/ethnicity, 
sex, interview mode, and interaction between sex and interview 
mode are controlled. Figure 2 shows the odds ratios over time. 
Within each subsample, the results suggest increasing or flat 
odds, but no decrease over time. These findings provide further 
evidence that there is no declining trend in odds of any cognitive 
impairment or dementia over the time period from 1996 to 2014.
Second, models in which we use combinations of al-
ternative specifications for age (quadratic, categorical), time 
(continuous, two different categorizations), and practice 
effects (continuous, square root, two different categorizations) 
TABLE 2. OR and 95% CI from Logistic Regression Models for Any Cognitive Impairment and Dementia
 
 
Any Cognitive Impairment Dementia
M1 M2 M3 M1 M2 M3
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Time (unit: 10 years) 0.85 (0.82, 0.89) 1.14 (1.06, 1.22) 1.37 (1.29, 1.46) 0.87 (0.82, 0.93) 1.29 (1.16, 1.44) 1.54 (1.39, 1.70)
Race/ethnicity (ref. White)
  Black 4.8 (4.4, 5.3) 4.6 (4.2, 5.1) 3.4 (3.2, 3.7) 4.4 (3.9, 5.1) 4.3 (3.8, 4.9) 3.1 (2.8, 3.4)
  Latinx 4.2 (3.6, 4.8) 4.0 (3.5, 4.6) 2.1 (1.8, 2.4) 3.3 (2.8, 3.9) 3.2 (2.7, 3.7) 1.8 (1.5, 2.1)
  Other 2.4 (1.6, 3.5) 2.3 (1.6, 3.4) 2.1 (1.6, 2.8) 2.0 (1.2, 3.4) 1.9 (1.1, 3.4) 1.7 (1.1, 2.8)
Man (ref. woman) 1.1 (1.1, 1.2) 1.1 (1.0, 1.2) 1.1 (1.1, 1.2) 1.1 (1.0, 1.2) 1.0 (0.92, 1.1) 1.0 (0.93, 1.1)
Age (unit: 10 years) 1.4 (1.3, 1.6) 1.9 (1.7, 2.1) 1.4 (1.3, 1.6) 2.4 (2.1, 2.9) 3.2 (2.7, 3.7) 2.5 (2.1, 3.0)
Age squared (unit: 10 years) 1.1 (1.1, 1.1) 1.1 (1.0, 1.1) 1.1 (1.1, 1.1) 1.0 (1.0, 1.1) 1.0 (1.0, 1.0) 1.0 (1.0, 1.0)
Interview mode (ref. face-to-face)
  Telephone 0.80 (0.76, 0.83) 0.79 (0.75, 0.83) 0.81 (0.77, 0.85) 0.82 (0.75, 0.89) 0.78 (0.72, 0.86) 0.82 (0.75, 0.89)
  Proxy 6.4 (5.7, 7.3) 4.4 (3.9, 5.0) 4.5 (3.9, 5.2) 19 (17, 22) 11 (9.4, 12) 11 (9.5, 13)
  Telephone × man 1.1 (1.0, 1.2) 1.1 (1.0, 1.2) 1.2 (1.1, 1.3) 0.93 (0.82, 1.1) 0.95 (0.84, 1.1) 1.0 (0.89, 1.1)
  Proxy × man 0.42 (0.36, 0.49) 0.46 (0.40, 0.54) 0.40 (0.34, 0.47) 0.33 (0.29, 0.39) 0.37 (0.32, 0.43) 0.33 (0.28, 0.39)
Test number (ref. 1st)
  2nd  0.94 (0.88, 1.00) 0.94 (0.88, 1.00)  0.91 (0.83, 1.00) 0.91 (0.83, 1.00)
  3–4  0.77 (0.72, 0.82) 0.78 (0.73, 0.83)  0.66 (0.59, 0.74) 0.66 (0.59, 0.74)
  5–7  0.58 (0.52, 0.64) 0.60 (0.54, 0.66)  0.46 (0.40, 0.53) 0.48 (0.42, 0.55)
  8+  0.46 (0.40, 0.53) 0.48 (0.43, 0.54)  0.33 (0.27, 0.40) 0.34 (0.28, 0.42)
Educational attainment (ref. less than high school)
  HS/GEDa   0.31 (0.29, 0.33)   0.35 (0.32, 0.38)
  Associate +   0.13 (0.12, 0.14)   0.18 (0.15, 0.21)
Constantb 0.054 (0.048, 0.061) 0.048 (0.043, 0.055) 0.17 (0.15, 0.20) 0.0039 (0.0031, 0.0049) 0.0039 (0.0031, 0.0048) 0.012 (0.0092, 0.015)
Person-waves 179,236 179,236 179,236 179,236 179,236 179,236
M1 includes covariates time, race/ethnicity, age, age squared, and the interaction between sex and interview mode. M2 adds test number. M3 adds educational attainment.
aHS indicates high school diploma. GED is general educational development, a set of tests that provides certification considered equivalent to a US high school diploma.
bThe constant represents the baseline odds (not odds ratio) when categorical variables are at their reference values and age and time at values to which these were centered (age 
50, year 2000).
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predominantly indicate increasing odds ratios over time of any 
cognitive impairment and dementia prevalence (eTable 6; http://
links.lww.com/EDE/B677). In the large number of coefficients 
produced through these alternative specifications (252), a small 
number of results suggest weakly negative trends (e.g., for de-
mentia, there are three negative coefficients out of 84). The ex-
ceptional coefficients that do not suggest flat or increasing trends 
are based on the crudest categorizations in which both age and 
practice effects are coded in such coarse categories that they are 
likely to only partially control for the underlying concepts.
Third, we use a simulation experiment to test whether 
the survey circumstances of sample refreshment (reducing 
the collinearity between age and time) and nonresponse (re-
ducing collinearity between number of tests taken, age, and 
time) alleviate collinearity enough for robust coefficient 
estimation. In short (eAppendix V; http://links.lww.com/
EDE/B677 for details), after generating simulated cognitive 
TABLE 4. Subpopulation Analysis: OR and 95% CI for the 10-year Time Trend from Regression Models for Dementia, 




Model 1 Model 2 Model 1 Model 2
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex-stratified 0.86 (0.79, 0.93) 1.31 (1.13, 1.52) 0.89 (0.82, 0.98) 1.28 (1.13, 1.44)
Age group     
  50–64 1.07 (0.81, 1.43) 1.18 (0.89, 1.57) 1.01 (0.83, 1.24) 1.04 (0.85, 1.27)
  65–74 0.78 (0.67, 0.91) 1.13 (0.95, 1.34) 0.73 (0.61, 0.88) 1.03 (0.85, 1.25)
  75–84 0.78 (0.70, 0.86) 1.16 (0.99, 1.35) 0.91 (0.80, 1.03) 1.44 (1.23, 1.68)
  85+ 0.94 (0.82, 1.08) 1.38 (1.18, 1.62) 1.01 (0.85, 1.21) 1.65 (1.32, 2.07)
Race/ethnicity     
  White 0.83 (0.77, 0.90) 1.29 (1.13, 1.48) 0.87 (0.78, 0.98) 1.31 (1.13, 1.51)
  Black 0.77 (0.67, 0.88) 1.16 (0.96, 1.40) 0.93 (0.80, 1.08) 1.24 (1.06, 1.45)
  Latinx 1.28 (0.98, 1.68) 1.79 (1.39, 2.29) 0.95 (0.68, 1.32) 1.18 (0.87, 1.60)
  Other 0.69 (0.45, 1.07) 0.95 (0.62, 1.47) 0.98 (0.55, 1.75) 1.28 (0.73, 2.23)
Education     
  <HS 1.06 (0.94, 1.19) 1.67 (1.42, 1.96) 1.15 (0.97, 1.36) 1.58 (1.32, 1.90)
  HS/GEDa 1.03 (0.93, 1.14) 1.55 (1.32, 1.81) 1.04 (0.92, 1.18) 1.42 (1.22, 1.66)
  Associate + 0.89 (0.68, 1.17) 1.27 (0.97, 1.66) 1.09 (0.84, 1.41) 1.52 (1.17, 1.99)
Model 1 does not adjust for number of tests taken. Model 2 includes number of tests as a covariate. The models are estimated separately for men and women. Time is in 10-year 
units. Results by age group are obtained by including an interaction term between age group and time. Results by race/ethnicity are obtained by including an interaction term between 
race/ethnicity and time. Results by education are obtained by including an interaction term between education and time. Models denoted by “model 1” include as covariates age, age 
squared, race/ethnicity, and interview mode, except the model estimating age group–specific results, which includes categorical age instead of continuous and quadratic age. Models 
denoted by “model 2” additionally include the number of tests taken as a covariate.
aGED is general educational development, a set of tests that provides certification considered equivalent to a US high school diploma.
HS indicates high school diploma.
TABLE 3. Predicted Prevalence and Annual Percent Change in Any Cognitive Impairment and Dementia for Ages 50 and Over 
from 1996 and 2014
 
Any Cognitive Impairment (%) Dementia (%)
1996 2014
Annual % Changea  
(95% CI) 1996 2014
Annual % Changea  
(95% CI)
Women       
  Model 1 22.6 18.4 −1.1 (−1.5, −0.8) 6.7 5.6 −1.0 (−1.5, −0.8)
  Model 2 18.7 21.2 0.7 (0.1, 1.3) 5.1 7.0 1.7 (0.8, 2.6)
Men       
  Model 1 21.4 18.3 −0.9 (−1.2, −0.5) 5.1 4.3 −0.9 (−1.6, −0.2)
  Model 2 17.6 21.0 1.0 (0.5, 1.4) 3.8 5.4 2.0 (1.0, 2.9)
Model 1 includes covariates time, race/ethnicity, age, age squared, and the interaction between gender and interview mode. Model 2 adds test number.
aAnnual percent change is calculated as 100 × [(P2014/P1996)^(1/18)−1], where P2014 and P1996 are the predicted probabilities in years 2014 and 1996, respectively.
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function trajectories for HRS respondents, we reestimate the 
simulation model from the simulated data and determine that 
we can estimate the coefficients accurately despite collinearity 
(eTable 7; http://links.lww.com/EDE/B677). In addition, this 
exercise demonstrates that if practice effects are present, their 
omission can introduce a serious bias to the time trend.
DISCUSSION
Using the HRS, a nationally representative, population-
based panel survey, we examine trends in the prevalence of 
both any cognitive impairment and dementia across almost 
20 years, accounting for prior test experience. We find con-
sistency across our results that once prior test experience is 
Any cognitive impairmentA
B
FIGURE 2. Odds ratios and 95% 
confidence intervals for time from 
logistic regression models for any 
impairment (A) and dementia (B), 
estimated from subsamples re-
stricted to first, second, fourth, or 
sixth test (The reference category is 
1996–1998 for tests 1 and 2, 2002–
2004 for test 4, and 2004–2006 for 
test 6).
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considered, trends in cognitive impairment increase. This 
holds for all subpopulations and is true for prevalence of any 
impairment, cognitive impairment without dementia, and de-
mentia, as well as when measuring cognitive function contin-
uously. Latinas, the least educated, and the oldest age group 
experienced the largest increases in prevalence of impairment. 
Especially for the least educated and oldest, this may be driven 
by lengthening life expectancies, in general, as well as people 
living longer with dementia.
From a transdisciplinary perspective, the discrepancy 
between our results and other findings of declining risk of cog-
nitive impairment is not surprising.3,5,7,49,50 Medical research-
ers warn that when assessments of cognitive decline are based 
on repeated, analogous tests, results will be biased if practice 
effects are not considered; respondents’ test-taking ability 
improves over repeated exposure, inflating cognitive func-
tion scores.27–32 Indeed, community-based or clinical studies 
that use a medical evaluation for diagnosis are less likely to 
find declining trends in dementia prevalence or incidence than 
population-based survey data.8,51–56
Some studies acknowledge possible concerns with prac-
tice effects, but dismiss them as unlikely to be important.49,57 
However, more recent studies that explicitly model practice 
effects in contexts other than population-based research on 
cognitive impairment find effect sizes large enough to bias 
results.12,26,28,29,32,39,58,59 Calamia and colleagues40 review the 
practice effects literature and suggest that the effect size may 
be up to a quarter of a standard deviation. They conclude that 
practice effects cannot be ignored, a position echoed by the 
American Academy of Clinical Neuropsychology, as well as 
other cognitive scientists.27,28,30,60
Methodologic Considerations
While there is general agreement among cognitive 
scientists that we should account for practice effects when 
modeling cognitive decline, a range of details makes practice 
effects challenging to model. Practice effects are design-spe-
cific, and therefore likely vary strongly across studies. How 
practice effects accumulate is uncertain:40,60,61 the largest prac-
tice effect may be between the first and second test39,62; there 
may be diminishing returns61; or effects may last only up until 
a certain number of tests.12,58 We use several categorizations 
for practice effects to test the robustness of findings to func-
tional form. That practice effects, time, and aging are collinear 
could also pose problems. We test for various specifications of 
all three variables and find our results remarkably consistent, 
except for the crudest categorizations wherein age and prac-
tice effects only partially control for the concepts they are sup-
posed to measure (eTable 6; http://links.lww.com/EDE/B677).
Additionally, practice effects may depend on a variety 
of factors, including age, cohort, genetics (e.g., apolipopro-
tein E ε4 status), sex, race/ethnicity, health, level of education, 
baseline cognition, and time to death. In brief, the research 
on the association between practice effects and age, cohort, 
education, and baseline cognitive function are inconclusive; 
there is less support for an interaction between practice effects 
and sex, race/ethnicity, apolipoprotein E ε4, or cardiovascular 
health.12,59,63,64 Evidence does suggest that education and 
baseline cognitive function may be positively associated with 
practice effects29,39; although, others find no pattern.59,63–66 In 
this analysis, however, the emphasis is not on the specification 
of the practice effects, but on the importance of accounting 
for them when analyzing trends in prevalence from panel data. 
Our results show the importance of accounting for practice 
effects when analyzing prevalence of cognitive impairment. 
Further research should analyze whether practice effects have 
a similar impact on incidence estimates.
Other survey design factors are also important. The 
number of tests taken, at the individual level, is correlated 
with the number of years that a person has stayed in the 
survey, which also captures differential attrition by cognitive 
status. It is possible that respondents who have poor cogni-
tive function are more likely to leave the study, due to failing 
function, comorbidities, or even stigma associated with ina-
bility to complete the survey.26 Because of the high correlation 
between number of tests and time-on-study, interpretation of 
the coefficient for prior tests is difficult. This coefficient can 
capture the effects of both prior tests and selective attrition. 
However, our robustness checks examining individuals at dif-
ferent waves of participation who have the same number of 
prior tests (Figure 2) and our simulation exercise (eAppen-
dix V; http://links.lww.com/EDE/B677) should mitigate these 
concerns. Furthermore, our contribution is not focused on 
unbiased estimation of the practice effect, but on accurately 
estimating time trends in cognitive impairment. The latter is 
robust to the interpretational vagueness that comes with col-
linearity between number of tests taken and number of years 
in the survey.
Another survey design feature is that the HRS shifted 
to more face-to-face interviews in 2006; since then, the use 
of proxies has declined from approximately 10% to only 
5.6% in 2014.5,10 Proxy-use is positively associated with 
cognitive impairment,67 so excluding proxies may introduce 
negative bias—a larger share of the population may appear 
cognitively impaired in more recent years when fewer prox-
ies were used. Though this may be the case in modeling the 
continuous measure for cognitive function (eTable 1; http://
links.lww.com/EDE/B677), our logistic regression analyses 
include proxy interviewees. We also include an interaction be-
tween interview mode and sex because women with proxies 
are more than twice as likely to be assessed as demented than 
proxied men. All results pointing to the same conclusion lends 
confidence that changes in interview mode are not driving our 
results.
Of course, despite all efforts to minimize the impact of 
nonrandom loss to follow-up, it is possible that such missing-
ness still influences our estimated trends. However, it seems 
unlikely that such missingness would differentially influence 
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our results that control versus do not control for practice 
effects. Thus, even in the presence of biasing missingness, it 
seems unlikely that this missingness would influence our con-
clusions regarding the importance of controlling for prior test 
experience.
As we do, Choi and colleagues26 attempt to control for 
various survey design features in analyzing the HRS, including 
prior testing. They also find no downward trend in cognitive 
impairment. Our analyses, however, diverge in several dimen-
sions. Most important, although Choi et al.26 note that their es-
timate of the time trend (no improvement) differs from much 
of the literature (that finds improvement), they write that ana-
lyzing the reasons for this difference is beyond the scope of 
their article. They speculate that the reasons might be related 
to, among other factors, how health conditions are modeled. 
However, practice effects are not mentioned among the poten-
tial candidates that could be responsible for the differences 
in time trends between the Choi et al.26 article and the ma-
jority of the literature. Our article directly addresses this issue 
and shows how whether one controls or does not control for 
practice effects changes the estimated time trend in cognitive 
impairment. Additional important differences between Choi 
et al.26 and our analysis include that Choi et al.26 provide a 
rich analysis of socioeconomic disparities in cognitive impair-
ment, but do not analyze dementia, and they focus on a rela-
tively young population (age 55–69).
In sum, once we take prior testing experience into con-
sideration, we find no evidence for improving trends in prev-
alence of any cognitive impairment or dementia from 1996 to 
2014. These results are remarkably robust to alternative mod-
eling specifications. Although there are distinct challenges 
in modeling practice effects, researchers estimating trends 
in cognitive impairment based on panel data should account 
for prior experience. Otherwise, trends will be downwardly 
biased, which could be misinterpreted as a decline in preva-
lence. Our results showing increasing time trends in cognitive 
impairment and dementia indicate that the population-level 
burden of cognitive impairment may be underestimated.
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